Back to Search
Start Over
Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4).
- Source :
-
Urolithiasis [Urolithiasis] 2023 Jun 05; Vol. 51 (1), pp. 85. Date of Electronic Publication: 2023 Jun 05. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 2194-7236
- Volume :
- 51
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Urolithiasis
- Accession number :
- 37273015
- Full Text :
- https://doi.org/10.1007/s00240-023-01455-1